RWLK - ReWalk Robotics Ltd Stock Price, Fair Value and News

$5.100.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

RWLK Price Action

Last 7 days

10.4%

Last 30 days

460.2%

Last 90 days

568.0%

Trailing 12 Months

665.8%

RWLK RSI Chart

RWLK Valuation

Market Cap

45.9M

Price/Earnings (Trailing)

-2.38

Price/Sales (Trailing)

1.84

EV/EBITDA

-1.87

Price/Free Cashflow

-2.05

RWLK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

RWLK Fundamentals

RWLK Revenue

Revenue (TTM)

25.0M

Rev. Growth (Yr)

39.18%

Rev. Growth (Qtr)

-8.63%

RWLK Earnings

Earnings (TTM)

-19.3M

Earnings Growth (Yr)

59.05%

Earnings Growth (Qtr)

28.35%

RWLK Profitability

Operating Margin

35.26%

EBT Margin

-77.36%

Return on Equity

-56.95%

Return on Assets

-42.17%

Free Cashflow Yield

-48.7%

RWLK Investor Care

Shares Dilution (1Y)

2.72%

Diluted EPS (TTM)

-2.23

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	18.6M	23.3M	25.0M	0
2023	5.9M	5.6M	8.4M	13.9M
2022	5.5M	5.7M	4.6M	5.5M
2021	4.9M	4.7M	5.9M	6.0M
2020	4.1M	4.8M	4.4M	4.4M
2019	6.5M	5.7M	5.3M	4.9M
2018	6.8M	6.6M	6.5M	6.5M
2017	6.3M	7.5M	7.8M	7.8M
2016	5.2M	5.4M	5.6M	5.9M
2015	3.9M	3.8M	3.8M	3.7M
2014	2.2M	2.8M	3.4M	4.0M
2013	0	0	0	1.6M
2012	0	0	0	972.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About ReWalk Robotics Ltd

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

CEO	Mr. Lawrence J. Jasinski BS, MBA
WEBSITE	rewalk.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	56

ReWalk Robotics Ltd Frequently Asked Questions

What is the ticker symbol for ReWalk Robotics Ltd? What does RWLK stand for in stocks?

RWLK is the stock ticker symbol of ReWalk Robotics Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ReWalk Robotics Ltd (RWLK)?

As of Thu Oct 31 2024, market cap of ReWalk Robotics Ltd is 45.89 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RWLK stock?

You can check RWLK's fair value in chart for subscribers.

Is ReWalk Robotics Ltd a good stock to buy?

The fair value guage provides a quick view whether RWLK is over valued or under valued. Whether ReWalk Robotics Ltd is cheap or expensive depends on the assumptions which impact ReWalk Robotics Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RWLK.

What is ReWalk Robotics Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Oct 31 2024, RWLK's PE ratio (Price to Earnings) is -2.38 and Price to Sales (PS) ratio is 1.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RWLK PE ratio will change depending on the future growth rate expectations of investors.